Exclusive special offer and discount title banner vector image

GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET FORECAST 2024-2032

SCOPE OF THE REPORT

Global Pain Management Drugs and Devices Market by Product (Disposable Mixers, Single-use Bioreactors, Single-use Assemblers, Tubing Assemblies, Depth Filters, Tangential-flow Filtration Devices) Market by Application (Monoclonal Antibody Production, Plant Cell Cultivation, Patient-specific Cell Therapies, Vaccine Production) Market by Method (Filtration, Storage, Mixing, Purification, Cell Culture) Market by End-user (Biopharmaceutical Manufacturers, Contract Research Organization and Manufacturers, Life Science R&d Companies and Academic Research) by Geography


MARKET OVERVIEW

The global pain management drugs and devices market is approximated to grow at a CAGR of 3.70% during the forecast period 2024-2032

The global pain management drugs and devices market encompasses pharmaceutical, biotechnology, and medical device products used to alleviate acute and chronic pain among patient populations. The demand for effective pain management remains considerable within healthcare systems, driven by an aging population vulnerable to inflammatory and neuropathic pain, along with a high number of patients undergoing surgery or affected by diseases associated with pain. 

The market includes traditional non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, and analgesics. Additionally, it comprises implants, neurostimulation devices, analgesic infusion pumps, ablation devices, and other emerging innovations in devices utilized for pain relief therapy. Technological progress has facilitated the introduction of novel drug classes and delivery mechanisms, along with minimally invasive neuromodulation devices that offer benefits over traditional systemic pain medication, including minimized side effects.

Pain Management Drugs And Devices Market

Read our latest blog on the Pain Management Drugs And Devices Market

GROWTH ENABLERS

Key growth enablers of the global pain management drugs and devices market:

  • Growing biopharma industry and rising biologics demand
  • Flexibility and cost-efficiency over stainless steel equipment
    • Plastic equipment and components such as tubing, valve bags, and single-use bioreactors are seeing increased utilization in pain management biopharmaceutical manufacturing. Compared to traditional stainless-steel equipment, plastics provide more flexibility to scale production up and down to meet fluctuating clinical demand for analgesic drugs and neuromodulation devices. 
    • The ability to add modular and mobile production capacity without major facility investments also enables small-batch precision medicine approaches. Moreover, by reducing cleaning validation and cross-contamination risk, single-use plastics allow for multi-product facilities.
  • Increased R&D spending and innovations in single-user technologies
  • Focus on efficiency and quality in bioprocessing
  • Adoption of continuous manufacturing and process intensification

GROWTH RESTRAINTS

Key growth restraining factors of the global pain management drugs and devices market: 

  • Issues with extractable and leachable in single-use systems
  • Limitations in scaling up (>2,000l) using single-use bioreactors
  • Lack of long-term stability data for some polymers
    • Plastic equipment offers benefits in pharmaceutical manufacturing. The limited availability of long-term stability data for certain polymer components acts as a constraint to their widespread adoption in pain medication and device production processes. Additionally, the intricate manufacturing requirements of analgesic biologics and implantable neuromodulation devices contribute to delays in achieving the necessary safety and efficacy profiles for clinical use.
    • Regulators require extensive stability testing data to ensure there are no risks of container components leaching or impairing final production quality over time. Accumulating stability datasets spanning 10 to 20 years for all plastics has proven to be a challenging task. Therefore, manufacturers striving to balance innovation objectives with patient safety requirements face difficulties in fully validating plastic systems for long-term commercial scalability across various pain applications, thereby impeding widespread adoption.
  • Requirement for additional storage and disposal logistics
  • Perceived risk of contamination in single-use equipment

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Pain Management Drugs and Devices Market | Top Market Trends

  • The integration of sensor devices, software analytics, artificial intelligence, and cloud computing is enabling connected drug-device and app combinations that allow for improved personalized chronic and postoperative pain monitoring and self-management. By gathering real-world patient data, these digital pain platforms support the optimization of treatment approaches, dosing, and predictive prevention based on actionable insights from integrated health information exchanges.
  • Complex biological drugs, including monoclonal antibodies and cell and gene therapies, have demonstrated promising results in addressing specific pain disorders by targeting fundamental biological pathways. These innovative approaches move beyond symptomatic treatment, directly influencing disease processes. This proves especially beneficial for managing complex pain conditions that conventional therapies struggle to address effectively.

MARKET SEGMENTATION

Market Segmentation – Product, Application, Method, and End-User –

Market by Product: 

  • Disposable Mixers
    • Disposable mixers and bioreactor systems are increasingly utilized in the manufacturing of analgesic medications and advanced cell and gene therapies for pain management. These single-use systems offer advantages in terms of flexibility, efficiency, and modular scale-up capabilities, surpassing traditional stainless-steel equipment. Single-use disposable mixers contribute to improved standardization, simplifying the production of small batches of precise pain treatments customized to individual needs.
    • Requiring minimal cleaning, disposable mixers also reduce the risk of cross-contamination, making them suitable for multi-product facilities in the expanding pain management market. As the market leans towards continuous bioprocessing, integrated disposable mixing technologies serve as important components for pain management developers and contract manufacturers. These technologies enable the implementation of hybrid systems, facilitating real-time process optimization.
  • Single-Use Bioreactors
  • Single-Use Assemblers
  • Tubing Assemblies
  • Depth Filters
  • Tangential-flow Filtration Devices

Market by Application: 

  • Monoclonal Antibody Production
    • Monoclonal antibodies present innovative strategies for addressing specific intractable chronic pain conditions. They target precise cells and signaling pathways involved in inflammation, nerve sensitization, and other processes contributing to persistent pain. The production of these intricate biologics involves extensive optimization and process control throughout the multi-step mammalian cell culture manufacturing process.
    • Disposable technologies such as single-use bioreactors, connectors, and film-based equipment offer the efficiency, flexibility, and scalability required for the precise production of monoclonal antibodies.
  • Plant Cell Cultivation
  • Patient-Specific Cell Therapies
  • Vaccine Production

Market by Method:

  • Filtration
  • Storage
  • Mixing
  • Purification
  • Cell Culture

Market by End-User: 

  • Biopharmaceutical Manufacturers
  • Contract Research Organization and Manufacturers
  • Life Science R&D Companies and Academic Research

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific represents significant opportunities in pain management owing to a vast patient base and healthcare infrastructure growth. An aging population prone to chronic pain, along with rising surgery volumes, requires acute pain control. 
    • It is estimated over 65% of Chinese adults and 37% of Indians live with some form of chronic pain. Improving diagnosis and medical access further taps addressable groups. Multinationals establishing local manufacturing and partnerships with distribution networks also enable regional expansion.
    • Supportive government initiatives around digital health and value-based care incentivize integrated pain management adoption. Though cost sensitivities exist, unmet needs from the over 60% of global cancer cases in the Asia-Pacific ensure a strong demand for pain medications and neuromodulation devices with innovations catering to diverse populations.
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Major players in the global pain management drugs and devices market: 

  • Sartorius AG 
  • Danaher Corp 
  • Thermo Fisher Scientific Inc 
  • Merck KGaA 
  • Avantor Inc 
  • Eppendorf SE

Key strategies adopted by some of these companies:

  • In September 2022, Danaher’s Cytiva commenced a new single-use bioprocessing consumables factory in the United Kingdom, enabling over 500 million biologic drug and cell/gene therapy doses annually for pain medication production scaleup.
  • In November 2022, Sartorius acquired Albumedix, an innovative recombinant albumin supplier, to enhance cell culture media solutions critical for the scalable manufacturing of pain biologics, including analgesics and immunomodulators.
  • In December 2022, Thermo Fisher acquired PeproTech’s CDMO business, further expanding its capacity to develop and produce recombinant proteins and cell/gene therapies and advancing new non-opioid pain treatments.
  • In October 2022, Avantor initiated a new distribution center in Singapore to provide essential single-use bioprocessing supplies, reagents and chemicals to Asian cell and gene therapy developers racing to treat pain.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2024-2032
Base Year2023
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedProduct, Application, Method, and End-User
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedSartorius AG, Danaher Corp, Thermo Fisher Scientific Inc, Merck KGaA, Avantor Inc, Eppendorf SE, Boston Scientific Corp, Endo International plc, Assertio Holdings Inc, Abbott, AbbVie Inc, AstraZeneca PLC, Eli Lilly and Co, Johnson & Johnson Services Inc, Vertex Pharmaceuticals

TABLE OF CONTENTS

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. MAJOR MARKET FINDINGS
      1. RISING CONTINUOUS MANUFACTURING, MODULAR FACILITY DESIGNS, END-TO-END INTEGRATED SOLUTIONS USE SINGLE-USE TECHNOLOGY
      2. GROWING DEMAND FOR SINGLE-USE MIXING SYSTEMS, CONNECTORS, AND BIOBAGS
      3. HYBRID APPROACH COMBINING STAINLESS STEEL AND SINGLE-USE SYSTEMS GAINING TRACTION
      4. ADVANCES IN POLYMER SCIENCE LEADING TO INNOVATIVE FILMS, CONNECTORS, SENSORS FOR IMPROVED PERFORMANCE
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. GROWING BIOPHARMA INDUSTRY AND RISING BIOLOGICS DEMAND
      2. FLEXIBILITY AND COST-EFFICIENCY OVER STAINLESS STEEL EQUIPMENT
      3. INCREASED R&D SPENDING AND INNOVATIONS IN SINGLE-USER TECHNOLOGIES
      4. FOCUS ON EFFICIENCY AND QUALITY IN BIOPROCESSING
      5. ADOPTION OF CONTINUOUS MANUFACTURING AND PROCESS INTENSIFICATION
    2. KEY RESTRAINTS
      1. ISSUES WITH EXTRACTABLE AND LEACHABLE IN SINGLE-USE SYSTEMS
      2. LIMITATIONS IN SCALING UP (>2,000L) USING SU BIOREACTORS
      3. LACK OF LONG-TERM STABILITY DATA FOR SOME POLYMERS
      4. REQUIREMENT FOR ADDITIONAL STORAGE AND DISPOSAL LOGISTICS
      5. PERCEIVED RISK OF CONTAMINATION IN SINGLE-USE EQUIPMENT
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. GROWTH OF COMPLEX BIOLOGICS LIKE MONOCLONAL ANTIBODIES, CELL AND GENE THERAPIES 
      2. INCREASING DEVELOPMENT OF RAPID, EASY-TO-USE POINT-OF-CARE DIAGNOSTIC TESTS
      3. INTEGRATION OF DIGITAL TECHNOLOGIES LIKE SENSORS, SOFTWARE, AI TO ENABLE SMART, CONNECTED DEVICES AND PERSONALIZED APPS
      4. MORE VALUE-BASED PARTNERSHIPS BETWEEN INDUSTRY AND HEALTHCARE STAKEHOLDERS TYING PAYMENT TO OUTCOMES
      5. WIDER ADOPTION OF PRECISION MEDICINE APPROACHES 
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES 
      2. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
      3. GROWTH PROSPECT MAPPING FOR CHINA 
      4. GROWTH PROSPECT MAPPING FOR UNITED ARAB EMIRATES 
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
    6. VALUE CHAIN ANALYSIS
      1. PHARMACEUTICAL MANUFACTURERS
      2. MEDICAL DEVICE MANUFACTURERS
      3. CLINICAL RESEARCH ORGANIZATIONS (CROS) AND TESTING LABS
      4. HEALTHCARE PROVIDERS AND DISTRIBUTORS
    7. KEY BUYING CRITERIA
      1. CLINICAL EFFICACY AND PATIENT OUTCOMES
      2. CUSTOMIZATION AND PERSONALIZATION OPTIONS
      3. COST-EFFECTIVENESS AND AFFORDABILITY
      4. USER-FRIENDLY AND EASY INTEGRATION WITH HEALTHCARE SYSTEMS
  5. MARKET BY PRODUCT
    1. DISPOSABLE MIXERS
    2. SINGLE-USE BIOREACTORS
    3. SINGLE-USE ASSEMBLERS
    4. TUBING ASSEMBLIES
    5. DEPTH FILTERS
    6. TANGENTIAL-FLOW FILTRATION DEVICES 
  6. MARKET BY APPLICATION 
    1. MONOCLONAL ANTIBODY PRODUCTION
    2. PLANT CELL CULTIVATION
    3. PATIENT-SPECIFIC CELL THERAPIES
    4. VACCINE PRODUCTION 
  7. MARKET BY METHOD 
    1. FILTRATION
    2. STORAGE
    3. MIXING
    4. PURIFICATION
    5. CELL CULTURE
  8. MARKET BY END-USER
    1. BIOPHARMACEUTICAL MANUFACTURERS
    2. CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS
    3. LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH
  9. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET DRIVERS
      3. NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET CHALLENGES
      4. NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET DRIVERS
      3. EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET CHALLENGES
      4. EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        6. BELGIUM
          1. BELGIUM PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET DRIVERS
      3. ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET CHALLENGES
      4. ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        5. THAILAND
          1. THAILAND PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        6. VIETNAM
          1. VIETNAM PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        7. INDONESIA
          1. INDONESIA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET DRIVERS
      3. REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET CHALLENGES
      4. REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET SIZE & OPPORTUNITIES
  10. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. SARTORIUS AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. DANAHER CORP
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3.  THERMO FISHER SCIENTIFIC INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. MERCK KGAA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5.  AVANTOR INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6.  EPPENDORF SE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. BOSTON SCIENTIFIC CORP
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      8. ENDO INTERNATIONAL PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. ASSERTIO HOLDINGS INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10. ABBOTT
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. ABBVIE INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      12. ASTRAZENECA PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      13. ELI LILLY AND CO
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      14. JOHNSON & JOHNSON SERVICES INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      15. VERTEX PHARMACEUTICALS
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – PAIN MANAGEMENT DRUGS AND DEVICES MARKET 

TABLE 2: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 4: GLOBAL DISPOSABLE MIXERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL DISPOSABLE MIXERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 6: GLOBAL SINGLE-USE BIOREACTORS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL SINGLE-USE BIOREACTORS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 8: GLOBAL SINGLE-USE ASSEMBLERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL SINGLE-USE ASSEMBLERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 10: GLOBAL TUBLING ASSEMBLIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL TUBLING ASSEMBLIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 12: GLOBAL DEPTH FILTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL DEPTH FILTERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: GLOBAL TANGENTIAL-FLOW FILTRATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL TANGENTIAL-FLOW FILTRATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 16: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 18: GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 20: GLOBAL PLANT CELL CULTIVATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL PLANT CELL CULTIVATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 22: GLOBAL PATIENT-SPECIFIC CELL THERAPIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL PATIENT-SPECIFIC CELL THERAPIES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)   

TABLE 24: GLOBAL VACCINE PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL VACCINE PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 26: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY METHOD, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY METHOD, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 28: GLOBAL FILTRATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: GLOBAL FILTRATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 30: GLOBAL STORAGE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 31: GLOBAL STORAGE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 32: GLOBAL MIXING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: GLOBAL MIXING MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 34: GLOBAL PURIFICATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 35: GLOBAL PURIFICATION MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 36: GLOBAL CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: GLOBAL CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 38: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 39: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 40: GLOBAL BIOPHARMACEUTICAL MANUFACTURERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: GLOBAL BIOPHARMACEUTICAL MANUFACTURERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 42: GLOBAL CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 43: GLOBAL CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 44: GLOBAL LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 45: GLOBAL LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 46: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 47: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 48: NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 49: NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 50: NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK

TABLE 51: KEY PLAYERS OPERATING IN NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET

TABLE 52: EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 53: EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 54: EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK

TABLE 55: KEY PLAYERS OPERATING IN EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET

TABLE 56: ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 57: ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 58: ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK

TABLE 59: KEY PLAYERS OPERATING IN ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET

TABLE 60: REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 61: REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY REGION, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 62: REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET REGULATORY FRAMEWORK

TABLE 63: KEY PLAYERS OPERATING IN REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET

TABLE 64: LIST OF MERGERS & ACQUISITIONS

TABLE 65: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 66: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 67: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR UNITED KINGDOM

FIGURE 5: GROWTH PROSPECT MAPPING FOR CHINA 

FIGURE 6: GROWTH PROSPECT MAPPING FOR UNITED ARAB EMIRATES 

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023

FIGURE 10: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY DISPOSABLE MIXERS, 2024-2032 (IN $ MILLION)

FIGURE 11: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY SINGLE-USE BIOREACTORS, 2024-2032 (IN $ MILLION)

FIGURE 12: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY SINGLE-USE ASSEMBLERS, 2024-2032 (IN $ MILLION)

FIGURE 13: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY TUBLING ASSEMBLIES, 2024-2032 (IN $ MILLION)

FIGURE 14: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY DEPTH FILTERS, 2024-2032 (IN $ MILLION)

FIGURE 15: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY TANGENTIAL-FLOW FILTRATION DEVICES, 2024-2032 (IN $ MILLION)

FIGURE 16: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023

FIGURE 17: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY MONOCLONAL ANTIBODY PRODUCTION, 2024-2032 (IN $ MILLION)

FIGURE 18: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY PLANT CELL CULTIVATION, 2024-2032 (IN $ MILLION)

FIGURE 19: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY PATIENT-SPECIFIC CELL THERAPIES, 2024-2032 (IN $ MILLION)

FIGURE 20: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY VACCINE PRODUCTION, 2024-2032 (IN $ MILLION)

FIGURE 21: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, GROWTH POTENTIAL, BY METHOD, IN 2023

FIGURE 22: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY FILTRATION, 2024-2032 (IN $ MILLION)

FIGURE 23: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)

FIGURE 24: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY MIXING, 2024-2032 (IN $ MILLION)

FIGURE 25: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY PURIFICATION, 2024-2032 (IN $ MILLION)

FIGURE 26: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY CELL CULTURE, 2024-2032 (IN $ MILLION)

FIGURE 27: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023

FIGURE 28: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY BIOPHARMACEUTICAL MANUFACTURERS, 2024-2032 (IN $ MILLION)

FIGURE 29: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY CONTRACT RESEARCH ORGANIZATION AND MANUFACTURERS, 2024-2032 (IN $ MILLION)

FIGURE 30: GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY LIFE SCIENCE R&D COMPANIES AND ACADEMIC RESEARCH, 2024-2032 (IN $ MILLION)

FIGURE 31: NORTH AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 32: UNITED STATES PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 33: CANADA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 34: EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 35: UNITED KINGDOM PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 36: GERMANY PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 37: FRANCE PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 38: ITALY PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 39: SPAIN PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 40: BELGIUM PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 41: REST OF EUROPE PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 42: ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET, COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 43: CHINA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 44: JAPAN PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 45: INDIA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 46: SOUTH KOREA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 47: THAILAND PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 48: VIETNAM PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 49: INDONESIA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 50: AUSTRALIA & NEW ZEALAND PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 51: REST OF ASIA-PACIFIC PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 52: REST OF WORLD PAIN MANAGEMENT DRUGS AND DEVICES MARKET, REGIONAL OUTLOOK, 2023 & 2032 (IN %)

FIGURE 53: LATIN AMERICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FIGURE 54: MIDDLE EAST & AFRICA PAIN MANAGEMENT DRUGS AND DEVICES MARKET, 2024-2032 (IN $ MILLION)

FAQ’s

FAQs

Pain management involves techniques and treatments designed to alleviate or reduce discomfort. This can include medications, physical therapy, and various medical devices aimed at improving the quality of life for individuals experiencing pain.

Pain management drugs and devices are widely prevalent, addressing a diverse range of conditions that cause discomfort. From readily available over-the-counter pain relievers to specialized medical devices, these solutions are accessible and utilized on a global scale.

Yes, there are non-pharmaceutical options for managing pain. These can include physical therapy, acupuncture, meditation, and lifestyle changes. Consult with healthcare professionals to explore a holistic approach to pain management tailored to individual needs.